Aquestive Therapeutics, Inc. (AQST) — Dilution Risk Analysis
Current Snapshot
Aquestive Therapeutics, Inc. (AQST) has a DilutionWatch score of 33/10 and is classified as MEDIUM risk. The score date in the source data is 2026-09-29T03:44:34.753246.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 33/10 Source (as of 2026-09-29T03:44:34.753246)
Recent SEC Filings
Recent filing forms in the source payload: 3 2, 4 8.
| Form | Filed | Accession |
|---|---|---|
| 3 | 2026-04-10 | 0001214659-26-004532 |
| 3 | 2026-03-11 | 0001214659-26-003133 |
| 4 | 2026-03-11 | 0001214659-26-003134 |
| 4 | 2026-03-11 | 0001214659-26-003140 |
| 4 | 2026-03-11 | 0001214659-26-003141 |
| 4 | 2026-03-11 | 0001214659-26-003142 |
| 4 | 2026-03-11 | 0001214659-26-003143 |
| 4 | 2026-03-11 | 0001214659-26-003144 |
| 4 | 2026-03-11 | 0001214659-26-003145 |
| 4 | 2026-03-11 | 0001214659-26-003146 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 29 months | Source |
| Three-year share count growth | 87.98% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 33/10) Source
- Cash Runway
- 29 months Source
- Share Count Growth (3-Year)
- 87.98% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.